Early post-treatment with pentoxifylline or dibutyryl cAMP attenuates Escherichia coli-induced acute lung injury in guinea pigs.

We examined effects of early post-treatment with the methylxanthine pentoxifylline (PTXF), or the cell-permeable adenosine 3', 5'-cyclic monophosphate (cAMP) analog dibutyryl cAMP (db-cAMP) on Escherichia-coli-induced acute lung injury in guinea pigs. Acute lung injury was assessed by measurements of lung water (lung wet/dry weight ratio; W/D ratio), the concentration ratio of 125I-albumin in bronchoalveolar lavage (BAL) fluid and lung tissue compared with plasma (albumin index; BAL-AI or tissue-AI), and total differential leukocyte count in BAL fluid. Mean arterial pressure (Pa) and peripheral WBC counts were monitored continuously over the 8-h experiment. Septicemia was induced by a bolus injection of 2 x 10(9)/kg live E. coli. Thirty minutes later the animals received a bolus injection followed by continuous infusion of PTXF (20 mg/kg + 20 mg/kg/h; n = 8) or db-cAMP (2 mg/kg + 2 mg/kg/h; n = 8) or saline (septic control; n = 8). Nonseptic control groups were also studied. The lung W/D ratio, BAL-AI, lung tissue-AI, and BAL leukocyte count increased significantly in the septic control group. The PTXF-septic and db-cAMP-septic groups showed no significant increase in lung W/D ratio, BAL-AI, and lung tissue-AI. However, there was no difference in BAL total and differential leukocyte count as compared with the septic control group. PTXF and db-cAMP had no effect on E. coli-induced changes in peripheral WBC count and Pa. Comparison in vitro experiments demonstrated that PTXF and db-cAMP inhibited the endotoxin-induced (E. coli) chemiluminescent response of isolated guinea-pig polymorphonuclear leukocytes (PMN).(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  M. Jochum,et al.  Effect of recombinant hirudin, a specific inhibitor of thrombin, on endotoxin-induced intravascular coagulation and acute lung injury in pigs. , 1990, The American review of respiratory disease.

[2]  T. Raffin,et al.  The effects of aminophylline and pentoxifylline on multiple organ damage after Escherichia coli sepsis. , 1989, The American review of respiratory disease.

[3]  T. Raffin,et al.  Granulocyte depletion prevents tumor necrosis factor-mediated acute lung injury in guinea pigs. , 1988, The American review of respiratory disease.

[4]  J. Weil,et al.  Pentoxifylline decreases endotoxin-induced pulmonary neutrophil sequestration and extravascular protein accumulation in the dog. , 1988, The American review of respiratory disease.

[5]  R. Strieter,et al.  Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxofylline , 1988 .

[6]  T. Raffin,et al.  Attenuation of acute lung injury in septic guinea pigs by pentoxifylline. , 1988, The American review of respiratory disease.

[7]  W. J. Novick,et al.  Inhibition of the inflammatory action of interleukin-1 and tumor necrosis factor (alpha) on neutrophil function by pentoxifylline , 1988, Infection and immunity.

[8]  T. Raffin,et al.  Tumor necrosis factor causes increased pulmonary permeability and edema. Comparison to septic acute lung injury. , 1988, The American review of respiratory disease.

[9]  E. W. Hall,et al.  Pulmonary edema after Escherichia coli peritonitis correlates with thiobarbituric-acid-reactive materials in bronchoalveolar lavage fluid. , 1988, The American review of respiratory disease.

[10]  G. Vercellotti,et al.  Pentoxifylline inhibits granulocyte and platelet function, including granulocyte priming by platelet activating factor. , 1988, The Journal of laboratory and clinical medicine.

[11]  C. Haslett,et al.  The pulmonary vascular sequestration of neutrophils in endotoxemia is initiated by an effect of endotoxin on the neutrophil in the rabbit. , 1987, The American review of respiratory disease.

[12]  J. Michael,et al.  Pharmacological modification of pulmonary vascular injury: possible role of cAMP. , 1987, Journal of applied physiology.

[13]  H. Bessler,et al.  Effect of Pentoxifylline on the Phagocytic Activity, cAMP Levels, and Superoxide Anion Production by Monocytes and Polymorphonuclear Cells , 1986, Journal of leukocyte biology.

[14]  W. Summer,et al.  Isoproterenol or aminophylline attenuate pulmonary edema after acid lung injury. , 1985, The American review of respiratory disease.

[15]  M. Peach,et al.  Role of Endothelial Cell Cytoskeleton in Control of Endothelial Permeability , 1982, Circulation research.

[16]  B. Hainau,et al.  Regulation of epithelial tight junction permeability by cyclic AMP , 1981, Nature.

[17]  R. Adelstein,et al.  Phosphorylation by cyclic adenosine 3':5'-monophosphate-dependent protein kinase regulates myosin light chain kinase. , 1980, Federation proceedings.

[18]  R. Wallace,et al.  Proteins iodinated by the chloramine-T method appear to be degraded at an abnormally rapid rate after endocytosis. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[19]  C. Persson,et al.  Vascular anti-permeability effects of beta-receptor agonists and theophylline in the lung. , 2009, Acta pharmacologica et toxicologica.

[20]  K. Brigham,et al.  Isoproterenol and aminophylline reduce lung capillary filtration during high permeability. , 1979, Journal of applied physiology: respiratory, environmental and exercise physiology.

[21]  K. Jakobs,et al.  Cyclic AMP and phagocytosis in alveolar macrophages: influence of hormones and dibutyryl cyclic AMP. , 1975, Journal of the Reticuloendothelial Society.

[22]  J. Coalson,et al.  Significance of leukocytes in endotoxic shock. , 1974, Experimental and molecular pathology.

[23]  B. Andersen,et al.  Single-step separation of red blood cells. Granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll-Hypaque. , 1974, Journal of immunological methods.

[24]  M. Kaliner,et al.  Immunologic release of histamine and slow reacting substance of anaphylaxis from human lung. V. Effects of prostaglandins on release of histamine. , 1973, Journal of immunology.

[25]  J. Collins,et al.  Changes in lung and body weight and lung water content in rats treated for hemorrhage with various fluids. , 1973, Surgery.

[26]  M. Kaliner,et al.  IMMUNOLOGICAL RELEASE OF HISTAMINE AND SLOW REACTING SUBSTANCE OF ANAPHYLAXIS FROM HUMAN LUNG , 1971, The Journal of experimental medicine.

[27]  E. Sutherland,et al.  Preparation of derivatives of adenosine 3′,5′-phosphate , 1967 .